DJ Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ slipped 1.00% to $455.45 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.13% to 5,976.97 and Dow Jones Industrial Average falling 1.79% to 42,197.79.
The stock's fall snapped a three-day winning streak.
Vertex Pharmaceuticals Inc. closed 12.39% short of its 52-week high of $519.88, which the company achieved on November 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as AbbVie Inc. $(ABBV)$ fell 0.70% to $191.08, Krystal Biotech Inc. (KRYS) fell 2.32% to $137.07, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 2.06% to $12.38.
Trading volume (934,402) remained 856,837 below its 50-day average volume of 1.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 13, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 13, 2025 16:37 ET (20:37 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.